As of April 18, 2025, Kyndryl (KD) has a market cap of $6.80 billion USD. According to our data, Kyndryl is ranked No.2121 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 18, 2025 | $6.80 B |
-15.55%
|
Dec 31, 2024 | $8.05 B |
66.51%
|
Dec 29, 2023 | $4.84 B |
86.87%
|
Dec 30, 2022 | $2.59 B |
-38.56%
|
Dec 31, 2021 | $4.21 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() IBM
IBM
|
$221.44 B |
0.005 M
|
![]() USA
|
![]() Accenture
ACN
|
$176.76 B |
-0.000 M
|
![]() Ireland
|
![]() DXC Technology
DXC
|
$2.60 B |
0.000 M
|
![]() USA
|
![]() Cognizant Technology Solutions
CTSH
|
$34.35 B |
-0.001 M
|
![]() USA
|
![]() Infosys
INFY
|
$68.69 B |
1.818 B
|
![]() India
|
![]() The Container Store
TCS
|
$9.15 M |
8.425 M
|
![]() USA
|
![]() Wipro
WIT
|
$28.94 B |
0.699 B
|
![]() India
|
![]() Atossa Therapeutics
ATOS
|
$80.49 M |
0.400 M
|
![]() USA
|
![]() CGI
GIB
|
$23.59 B |
2.521 B
|
![]() Canada
|
Market Cap | = | KD Stock Price | * | KD Shares Outstanding |
= | $29.22 | * | 0.23 B | |
= | $6.80 B |